<DOC>
	<DOCNO>NCT00001713</DOCNO>
	<brief_summary>Acute deep venous thrombosis ( ADVT ) low extremity common disorder . Traditional treatment anticoagulation therapy effective reducing associate risk pulmonary embolism , ineffective restoring patency venous system lower extremity . While systemic thrombolytic therapy show effective anticoagulation , catheter direct local thrombolytic therapy effective treatment restore venous patency . Current treatment regimen base use urokinase , infuse continuously catheter imbed thrombus . These treatment regimens require dos order 10,000,000 unit urokinase , result significant bleeding complication prohibitive cost . Experience NIH pulse-spray treatment axillary subclavian venous thrombosis rtPA indicate highly effective safe alternative thrombolytic regimen . The propose protocol design evaluate efficiency , safety , dose rtPA associate pulse spray direct rtPA treatment extensive venous thrombosis encounter low extremity .</brief_summary>
	<brief_title>Treatment Blood Clots Veins Legs</brief_title>
	<detailed_description>Acute deep venous thrombosis ( ADVT ) low extremity common disorder . Traditional treatment anticoagulation therapy effective reducing associate risk pulmonary embolism , ineffective restoring patency venous system lower extremity . While systemic thrombolytic therapy show effective anticoagulation , catheter direct local thrombolytic therapy effective treatment restore venous patency . Current treatment regimen base use urokinase , infuse continuously catheter imbed thrombus . These treatment regimens require dos order 10,000,000 unit urokinase , result significant bleeding complication prohibitive cost . Experience NIH pulse-spray treatment axillary subclavian venous thrombosis rtPA indicate highly effective safe alternative thrombolytic regimen . The propose protocol design evaluate efficiency , safety , dose rtPA associate pulse spray direct rtPA treatment extensive venous thrombosis encounter low extremity .</detailed_description>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Thrombophlebitis</mesh_term>
	<mesh_term>Plasminogen</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Tissue Plasminogen Activator</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>INCLUSION CRITERIA : Patients must 18 year old . A negative pregnancy test require female patient childbearing age . Only patient first onset acute DVT accept . Acute DVTLE must document ultrasonography venogram define thrombosis major deep vein segment popliteal vein le 14 day since onset symptom diagnosis . Extension thrombosis popliteal vein calf vein acceptable , isolated calf vein thrombosis treat protocol , benefit thrombolytic therapy outweigh risk . EXCLUSION CRITERIA : Current familial acquire bleed diathesis attributable heparin ( prothrombin time great 15 , PTT great 36 , fibrinogen le 150 mg/dL ) ; platelet count less 50,000/gL unsupportable platelet transfusion ; creatinine great 2 mg/dL ; severe hypertension ( systolic great 200 mm Hg , diastolic great 100 mm Hg ) ; atrial fibrillation ; know righttoleft shunt ; pregnancy ; breast feeding ; history anaphylactic reaction contrast medium ; history evidence heparininduced thrombocytopenia . Patients underlie coagulopathy must evaluate clear Dr. Horne consult NIH hematologist accept treatment protocol . Any follow within previous 2 week : gastrointestinal hemorrhage , active peptic ulcer disease , hemoptysis , genitourinary tract hemorrhage ( except microscopic hematuria ) , major surgery , trauma , biopsy noncompressible site . Any follow within previous 2 month : cerebrovascular accident hemorrhage . Patients hematocrits less 30 percent hemoglobin 's less 19 g/dl , base Clinical Center test ask participate Thrombolytic Enzyme Kinetic Study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2006</verification_date>
	<keyword>rtPA</keyword>
	<keyword>Catheter Directed</keyword>
	<keyword>Thrombolysis</keyword>
	<keyword>Anticoagulation</keyword>
	<keyword>Emboli</keyword>
	<keyword>Acute Deep Venous Thrombosis</keyword>
	<keyword>TPA</keyword>
	<keyword>DVT</keyword>
</DOC>